Skip to main content
SpringerLink
Log in
Book cover

Therapeutic Strategies in Primary and Metastatic Liver Cancer pp 103–111Cite as

Application and Results of Different Chemotherapy Regimens in Primary Liver Malignancies

  • Conference paper

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 100))

Abstract

The approach to treatment of patients with primary liver cancer has differed in different parts of the world. Where the difference in treatment approach is based on true pathological differences in the disease this is justified.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baker LH, Saiki JH, Jones SE, Hewlett JS, Brownlee RW, Stephens RL, Vaitkevicius VK (1977) Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group Study. Cancer Treat Rep 61: 1595–1597

    PubMed  CAS  Google Scholar 

  2. Berman C (1951) A study of incidence, clinical manifestations, pathology and aetiology in primary carcinoma of the liver. Lewis, London

    Google Scholar 

  3. Bukowski RM, Legha S, Saiki J, Eyre HJ, O’Brein R (1982) Phase II trial of m-amsa in hepatocellular carcinoma–a Southwest Oncology Group Study. Cancer Treat Rep 66 (8): 1651–1652

    PubMed  CAS  Google Scholar 

  4. Cavalli F, Rosenzweig M, Renard J, Goldhirsch A, Hansen HH (1981) Phase II study of oral VP-16–213 in hepatocellular carcinoma. Eur J Cancer Clin Oncol 17: 1079–1082

    Article  PubMed  CAS  Google Scholar 

  5. Cheng E, Lightdale C, Young C, Yagoda A, Fortner J, Golbey R (1983) Phase II trial of (mAMSA) 4’-9-(acridinylamino)methanesulfon-m-anisidide in primary liver cancer. Am J Clin On-col 6: 211–213

    CAS  Google Scholar 

  6. Chlebowski RT, Chan KK, Tong MJ, Weiner JM, Ryden VMJ, Bateman JR (1981) Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma. Cancer 48: 1088–1095

    Article  PubMed  CAS  Google Scholar 

  7. Chlebowski RT, Brzechwa-Adjukiewicz A, Cowden A, Block JB, Tong M, Chan KK (1982) Full dose adriamycin in hepatocellular carcinoma: clinical and pharmacokinetic results. Proc AACR 23: 110

    Google Scholar 

  8. Cochrane AMG, Murray-Lyon IM, Brinkley DM, Williams R (1977) Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma. Cancer 40: 609

    Article  PubMed  CAS  Google Scholar 

  9. Deutsch HF, Tsukada Y, Sasaki T, Hirai H (1982) The in vivo cytotoxic effects of daunomycinfatty acid complexes on rat hepatomas. Cancer Res (in press)

    Google Scholar 

  10. Evans AE, Land VJ, Newton WA, Randolph JG, Sather HN, Tefft M (1982) Combination chemotherapy (vincristine, Adriamycin, cyclophosphamide and 5-fluorouracil) in the treatment of children with malignant hepatoma. Cancer 50: 821–826

    Article  PubMed  CAS  Google Scholar 

  11. Falkson G (1959) Chemotherapie van Priroêre Lewerkarsinoom. Spekulum 3: 5–11

    Google Scholar 

  12. Falkson G (1975) Therapeutic approaches to hepatoma. Cancer Treat Rev 2: 73–76

    Article  PubMed  CAS  Google Scholar 

  13. Falkson G (1976) The treatment of liver cell cancer. In: Cameron HM, Lirisell DA, Warwick GP (eds) liver cell cancer. Elsevier, Amsterdam

    Google Scholar 

  14. Falkson G (1982) The management of tumours of the liver and biliary tract. In: Carter SK, Glatstein E, Livingston RB (eds) Principles of cancer treatment. McGraw-Hill, New York

    Google Scholar 

  15. Falkson G, Moertel CG, Lavin P, Pretorius FJ, Carbone PP (1978) Chemotherapy studies in primary liver cancer. Cancer 42: 2149–2156

    Article  PubMed  CAS  Google Scholar 

  16. Falkson G, Von Hoff D, Klaassen D, Du Plessis H, Van der Merwe CF, Van der Merwe AM, Carbone PP (1980) A phase II study of Neocarzinostatin (NSC 157365) in malignant hepatoma. Cancer Chemother Pharmacol 4: 33–36

    Article  PubMed  CAS  Google Scholar 

  17. Falkson G, Coetzer B, Klaassen DJ (1981) A phase II study of m-amsa in patients with primary liver cancer. Cancer Chemother Pharmacol 6: 127–129

    PubMed  CAS  Google Scholar 

  18. Falkson G, Moertel CC, Maclntyre JM, Lavin P, Engstrom PF, Carbone PP (1981) The value of cytostatic agents in the treatment of patients with primary liver cancer. In: Friedman M, Ogawa M, Kisner D (eds) Diagnosis and treatment of upper gastrointestinal tumors. Excerpta Medica, Amsterdam, pp 455–459

    Google Scholar 

  19. Falkson G, McIntyre J, Coetzer B, Schutt AJ, Engstrom PF, Carbone PP (1983) Phase II-III trial of neocarzinostatin versus m-amsa or Adriamycin in hepatocellular carcinoma. Proc AACR 24: 139

    Google Scholar 

  20. Falkson G, McIntyre JM, Moertel CG, Johnson LA, Scherman RC (1984) Primary liver cancer: an ECOG therapeutical trial. Cancer 54 (6): 970–977

    Article  PubMed  CAS  Google Scholar 

  21. Friedman MA, Demanes JD, Hoffman PG (1982) Hepatomas: hormone receptors and therapy. Am J Med 73: 362–366

    Article  PubMed  CAS  Google Scholar 

  22. Geddes EW, Falkson G (1970) Malignant hepatoma in the Bantu. Cancer 25: 1271–1278

    Article  PubMed  CAS  Google Scholar 

  23. Gillman T, Hathorn M, Lamont NME (1957) Alloxan as a possible therapeutic agent for primary carcinoma of the liver. Lancet 272 (6970): 687–688

    Article  Google Scholar 

  24. Ihde DC, Kane RC, Cohen MH, McIntyre KR, Minna JD (1977) Adriamycin therapy in american patients with hepatocellular carcinoma. Cancer Treat Rep 61: 1385–1387

    PubMed  CAS  Google Scholar 

  25. Lee Yeu Tsu M (1977) Systemic and regional treatment of primary carcinoma of the liver. Cancer Treat Rev 4: 195–212

    Article  Google Scholar 

  26. Leichman L, MacDonald B, Dindogin A, Samson M (1982) Platinum: a clinically active drug in advanced adenocarcinoma of the stomach. Proc AACR 23: 110

    Google Scholar 

  27. Melia WM, Westaby D, Williams R (1981) Diaminodichloride–platinum (cis-platinum) in the treatment of hepatocellular carcinoma. Clin Oncol 7: 275–280

    PubMed  CAS  Google Scholar 

  28. Melia WM, Johnson PJ, Williams R (1983) Induction of remission in hepatocellular carcinoma. A comparison of VP-16 and Adriamycin. Cancer 51: 206–210

    Article  PubMed  CAS  Google Scholar 

  29. Morstyn G, Ihde DC, Eddy JL, Bunn PA, Cohen MH, Minna JD (1982) Combination chemotherapy with doxorubicin and streptozotocin (DXC/STZ) in hepatocellular carcinoma ( HC ). Proc AACR 23: 113

    Google Scholar 

  30. Olweny CLM, Toya T, Katongole-Mbidde E, Mugerwa J, Kyalwazi SK, Cohen H (1975) Treatment of hepatocellular carcinoma with Adriamycin: preliminary communication. Cancer 36: 1250–1257

    Article  PubMed  CAS  Google Scholar 

  31. Olweny CL, Katongole-Mbidde E, Bahendeka S, Otim D, Mugerwa J, Kyalwazi SK (1980) Further experience in treating patients with hepatocellular carcinoma in Uganda. Cancer 46: 2717–2722

    Article  PubMed  CAS  Google Scholar 

  32. Stein SH, Ajani JA, Karlin DA, Nelson RS (1983) Combination chemotherapy of hepatocellular carcinoma with 5-fluorouracil, Adriamycin, mitomycin-C and methyl-CCNU ( FAMMe ). Proc ASCO 2: 120

    Google Scholar 

  33. Vogel CL, Bayley AC, Brooker RJ, Anthony PP, Ziegler JL (1977) A phase II study of Adriamycin (NSC 123 127) in patients with hepatocellular carcinoma from Zambia and the United States. Cancer 39: 1923–1929

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cancer Chemotherapy, University of Pretoria, Private Bag X 169, Pretoria, 0001, Republic of South Africa

    G. Falkson & B. J. Coetzer

Authors
  1. G. Falkson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. J. Coetzer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Chirurgische Klinik, Klinikum der Universität Heidelberg, Im Neuenheimer Feld 110, 6900, Heidelberg 1, Germany

    Christian Herfarth , Peter Schlag  & Peter Hohenberger ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Falkson, G., Coetzer, B.J. (1986). Application and Results of Different Chemotherapy Regimens in Primary Liver Malignancies. In: Herfarth, C., Schlag, P., Hohenberger, P. (eds) Therapeutic Strategies in Primary and Metastatic Liver Cancer. Recent Results in Cancer Research, vol 100. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82635-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-82635-1_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-82637-5

  • Online ISBN: 978-3-642-82635-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation